iFerex 150
This product looks safe
- No ingredients exceed tolerable upper intake levels
- Limited research evidence available for ingredients
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
Supplement Facts — Evidence Check
Other Ingredients
Label Claims — Verification
Target Groups
Product Information
📋 Directions for Use
Dosage and Administration: Adults: 1 capsule daily or as directed by your physician.
⚠️ Warnings & Precautions
Contraindications: iFerex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Adverse Events: You should call your doctor for medical advice about adverse events. To report a serious adverse event contact Nnodum Pharmaceuticals. 483 Northland Blvd., Cincinnati, OH, 45240.
Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control immediately. Keep this product and all drugs out of reach of children.
Dispense in a tight, light-resistant container with a child resistant closure.
🧪 Formulation Notes
Description: iFerex 150 capsules is a brown and orange capsule with marking "ziks 0203". It is a product of ferric iron complexed to a low molecular weight polysaccharide.
Indications and Usage: iFerex 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
Additional Information
Storage: Store at 20 degrees C - 25 degrees C (58 degrees - 77 degrees F): excursions permitted to 15 degrees C - 30 degrees C (59 degrees - 86 degrees F).
63044-0203-01
Product Details
Research Evidence
Compare Similar Products
